Condition Strategy

Dyslipidemia and High ApoB

Lower atherogenic lipid burden and vascular risk

Evidence Level A

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Guidance Summary

ApoB-centered risk management can sharpen atherogenic risk assessment beyond LDL-C alone and improve intervention targeting.

Top Interventions

  • dietary fat quality optimization
  • aerobic training
  • weight and glucose control

Monitoring Priorities

  • apoB
  • LDL-C
  • non-HDL-C
  • triglycerides

Source Links